Search

Displaying results 6731 - 6740 of 10000 in total
  1. Drug

    Empesertib

    go.drugbank.com/drugs/DB19473
    Investigational

    Empesertib has a monoisotopic molecular weight of 559.17 Da. … The usage of the INN stem '-sertib' in the name indicates that Empesertib is a serine/threonine kinase inhibitor.

  2. Drug

    Mevociclib

    go.drugbank.com/drugs/DB21454
    Investigational

    Mevociclib is under investigation in clinical trial NCT03134638 (A Study of SY-1365 in Adult Patients With Advanced Solid Tumors). Mevociclib has a monoisotopic molecular weight of 586.26 Da. … The usage of the INN stem '-ciclib' in the name indicates that Mevociclib is a cyclin dependant kinase inhibitor.

  3. Drug

    Risvodetinib

    go.drugbank.com/drugs/DB21602
    Investigational

    Risvodetinib has a monoisotopic molecular weight of 574.28 Da. … The usage of the INN stem '-tinib' in the name indicates that Risvodetinib is a tyrosine kinase inhibitor.

  4. Drug

    Levolansoprazole

    go.drugbank.com/drugs/DB20673
    Experimental

    The usage of the INN stem '-prazole' in the name indicates that Levolansoprazole is a benzimidazole derivative antiulcer medication. Levolansoprazole has a monoisotopic molecular weight of 369.08 Da.

  5. Drug

    Limnetrelvir

    go.drugbank.com/drugs/DB21677
    Experimental

    The usage of the INN stem '-trelvir' in the name indicates that Limnetrelvir is a antiviral 3CL protease inhibitor. Limnetrelvir has a monoisotopic molecular weight of 557.17 Da.

  6. Drug

    Epsametostat

    go.drugbank.com/drugs/DB21726
    Experimental

    The usage of the INN stem '-metostat' in the name indicates that Epsametostat is a histone N-methyltransferase inhibitor. Epsametostat has a monoisotopic molecular weight of 611.28 Da.

  7. Drug

    2X-121

    go.drugbank.com/drugs/DB16063
    Investigational

    2X-121 is under investigation in clinical trial NCT03562832 (Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the

  8. Drug

    Fosclevudine alafenamide

    go.drugbank.com/drugs/DB19113
    Investigational

    Fosclevudine alafenamide is under investigation in clinical trial NCT05238844 (A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With

  9. Drug

    ABT-072

    go.drugbank.com/drugs/DB15156
    Investigational

    ABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat

  10. Drug

    Enerisant

    go.drugbank.com/drugs/DB20605
    Experimental

    The usage of the INN stem '-isant' in the name indicates that Enerisant is a histamine H3​ receptor antagonist. Enerisant has a monoisotopic molecular weight of 398.23 Da.